Survival of Trial-Like and Non–Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP)

PURPOSEImmune checkpoint inhibitors (ICIs) is the initial line of management in advanced hepatocellular carcinoma (HCC), but survivals in the real world are not known.MATERIALS AND METHODSA retrospective study of patients with advanced HCC receiving ICIs (as first-line therapy or as later lines of t...

Descripción completa

Detalles Bibliográficos

Autores principales:	Anant Ramaswamy, Anand Kulkarni, George John, Amit Rauthan, Shekhar Patil, Ajay Duseja, Vineet Talwar, Senthil J. Rajappa, Nikhil Ghadyalpatil, Manav Wadhawan, Akash Shukla, Vamshi M. Krishna, Sujay Srinivas, Sunil Taneja, K. Mary Sravani, Sahaj Rathi, Prabhat Bhargava, Vikas Ostwal
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society of Clinical Oncology 2023-09-01
Colección:	JCO Global Oncology
Acceso en línea:	https://ascopubs.org/doi/10.1200/GO.23.00215
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!